Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$35.61 - $76.23 $22,790 - $48,787
-640 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$57.56 - $82.54 $11,512 - $16,508
200 Added 45.45%
640 $44.7 Million
Q4 2021

Jan 14, 2022

SELL
$72.5 - $100.68 $3,625 - $5,034
-50 Reduced 10.2%
440 $34.2 Million
Q3 2021

Oct 12, 2021

SELL
$90.24 - $124.05 $1.6 Million - $2.2 Million
-17,715 Reduced 97.31%
490 $46,000
Q4 2020

Feb 02, 2021

BUY
$99.61 - $142.12 $1.81 Million - $2.59 Million
18,205 New
18,205 $1.86 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.94B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.